HK1141511A1 - Process for the resolution of enantiomers and application thereof in the synthesis of ivabradine - Google Patents

Process for the resolution of enantiomers and application thereof in the synthesis of ivabradine

Info

Publication number
HK1141511A1
HK1141511A1 HK10108025.0A HK10108025A HK1141511A1 HK 1141511 A1 HK1141511 A1 HK 1141511A1 HK 10108025 A HK10108025 A HK 10108025A HK 1141511 A1 HK1141511 A1 HK 1141511A1
Authority
HK
Hong Kong
Prior art keywords
octa
dimethoxy
trien
bicyclo
nitrile
Prior art date
Application number
HK10108025.0A
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Daniel Dron
Eric Gojon
Maryse Phan
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40431490&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1141511(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1141511A1 publication Critical patent/HK1141511A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/48—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
HK10108025.0A 2008-08-29 2010-08-23 Process for the resolution of enantiomers and application thereof in the synthesis of ivabradine HK1141511A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804755A FR2935381B1 (fr) 2008-08-29 2008-08-29 Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine

Publications (1)

Publication Number Publication Date
HK1141511A1 true HK1141511A1 (en) 2010-11-12

Family

ID=40431490

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10108025.0A HK1141511A1 (en) 2008-08-29 2010-08-23 Process for the resolution of enantiomers and application thereof in the synthesis of ivabradine

Country Status (39)

Country Link
US (3) US8536365B2 (da)
EP (1) EP2166004B1 (da)
JP (2) JP5663154B2 (da)
KR (1) KR101119309B1 (da)
CN (1) CN101659631B (da)
AR (1) AR073147A1 (da)
AT (1) ATE483688T1 (da)
AU (1) AU2009208068B2 (da)
BR (1) BRPI0903051A2 (da)
CA (1) CA2676712C (da)
CL (1) CL2009001758A1 (da)
CY (1) CY1110943T1 (da)
DE (1) DE602009000256D1 (da)
DK (1) DK2166004T3 (da)
EA (1) EA015777B1 (da)
ES (1) ES2353251T3 (da)
FR (1) FR2935381B1 (da)
GE (1) GEP20125409B (da)
HK (1) HK1141511A1 (da)
HR (1) HRP20100679T1 (da)
JO (1) JO2786B1 (da)
MA (1) MA31228B1 (da)
ME (1) ME00835B (da)
MX (1) MX2009008443A (da)
MY (1) MY145992A (da)
NZ (1) NZ579270A (da)
PA (1) PA8840901A1 (da)
PE (1) PE20100234A1 (da)
PL (1) PL2166004T3 (da)
PT (1) PT2166004E (da)
RS (1) RS51554B (da)
SA (1) SA109300533B1 (da)
SG (1) SG159454A1 (da)
SI (1) SI2166004T1 (da)
TW (1) TWI404705B (da)
UA (1) UA105890C2 (da)
UY (1) UY32034A (da)
WO (1) WO2010023383A1 (da)
ZA (1) ZA200905566B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101478855B1 (ko) 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
CN101774969B (zh) * 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
EP2522647B1 (en) * 2011-05-10 2014-04-30 DSM IP Assets B.V. Process of separating chiral isomers of chroman compounds and their derivatives and precursors
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2986804A1 (fr) * 2012-02-09 2013-08-16 Servier Lab Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3002542B1 (fr) * 2013-02-28 2016-01-22 Servier Lab Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique et application a la synthese de l'ivabradine et de ses sels
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN106390519A (zh) * 2016-09-12 2017-02-15 华东理工大学 多柱模拟移动床色谱技术连续分离氨鲁米特外消旋体的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246948B2 (da) * 1972-04-26 1977-11-29
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2539415B1 (fr) * 1983-01-14 1985-09-13 Adir Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US5269482A (en) * 1991-09-30 1993-12-14 Shearing Ernest J Protective enclosure apparatus for magnetic propulsion space vehicle
EP0977031B1 (en) * 1997-04-15 2009-04-29 Hideyuki Nishizawa Solid-liquid countercurrent extraction continuously separating apparatus
GB0325055D0 (en) * 2003-10-27 2003-12-03 Smithkline Beecham Corp New process
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
KR101408128B1 (ko) * 2006-09-29 2014-06-16 카운실 오브 사이언티픽 엔드 인더스트리얼 리서치 유무기 하이브리드 키랄 흡수제 및 그 제조방법
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine

Also Published As

Publication number Publication date
SA109300533B1 (ar) 2013-07-04
BRPI0903051A2 (pt) 2010-05-25
PA8840901A1 (es) 2010-04-21
GEP20125409B (en) 2012-02-27
CY1110943T1 (el) 2015-06-10
MY145992A (en) 2012-06-08
FR2935381A1 (fr) 2010-03-05
US20100056778A1 (en) 2010-03-04
JP2010065032A (ja) 2010-03-25
ZA200905566B (en) 2010-05-26
CN101659631A (zh) 2010-03-03
JO2786B1 (en) 2014-03-15
US8536365B2 (en) 2013-09-17
DK2166004T3 (da) 2011-01-10
MA31228B1 (fr) 2010-03-01
CA2676712C (fr) 2012-09-18
CA2676712A1 (fr) 2010-02-28
ME00835B (me) 2012-03-20
MX2009008443A (es) 2010-03-23
KR101119309B1 (ko) 2012-03-19
KR20100027025A (ko) 2010-03-10
SI2166004T1 (sl) 2010-12-31
US8927758B2 (en) 2015-01-06
FR2935381B1 (fr) 2010-12-17
AU2009208068B2 (en) 2013-09-05
TWI404705B (zh) 2013-08-11
TW201010980A (en) 2010-03-16
HRP20100679T1 (hr) 2011-01-31
AR073147A1 (es) 2010-10-13
JP5663154B2 (ja) 2015-02-04
JP2013237675A (ja) 2013-11-28
US20130204032A1 (en) 2013-08-08
EA200901051A1 (ru) 2010-04-30
ES2353251T3 (es) 2011-02-28
PE20100234A1 (es) 2010-03-27
NZ579270A (en) 2010-12-24
US8778930B2 (en) 2014-07-15
DE602009000256D1 (de) 2010-11-18
JP5746733B2 (ja) 2015-07-08
UA105890C2 (uk) 2014-07-10
ATE483688T1 (de) 2010-10-15
SG159454A1 (en) 2010-03-30
CL2009001758A1 (es) 2010-12-24
US20130211070A1 (en) 2013-08-15
PL2166004T3 (pl) 2011-03-31
EP2166004A1 (fr) 2010-03-24
EP2166004B1 (fr) 2010-10-06
CN101659631B (zh) 2013-08-28
RS51554B (en) 2011-06-30
EA015777B1 (ru) 2011-12-30
UY32034A (es) 2010-01-29
PT2166004E (pt) 2010-10-27
WO2010023383A1 (fr) 2010-03-04
AU2009208068A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
HK1141511A1 (en) Process for the resolution of enantiomers and application thereof in the synthesis of ivabradine
NZ594087A (en) Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
MA31071B1 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et des sels d'addition a un acide pharmaceutiquement acceptable
NZ612592A (en) Process for the enzymatic synthesis of (7s)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) n-methyl methanamine, and application in the synthesis of ivabradine and salts thereof
MD4467B1 (ro) Procedeu de sinteză enzimatică a acidului (7S)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-triene-7-carboxilic sau a esterilor săi şi aplicarea lor în sinteza ivabradinei şi a sărurilor sale
CO6290712A2 (es) Asociacion de un inhibidor de corriente sinusual if y de un beta -bloqueante
WO2007118819A3 (de) Neue kristalline verbindungen
MD4468C1 (ro) Procedeu de sinteză prin lactamizare a ivabradinei şi a sărurilor sale de adiţie cu acizi acceptabili farmaceutic
CN102838493A (zh) 一种3-[(1r,2r)-3-(二甲胺基)-1-乙基-2-甲基丙基]苯酚的合成方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190823